SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹17 Cr | ₹14 Cr | ₹43 Cr | ₹12 Cr | ₹7.04 Cr |
What is the latest Total Current Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹7.04 Cr |
How is Total Current Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 22.12 | |
| Mar2024 | ₹14 Cr | -66.70 | |
| Mar2023 | ₹43 Cr | 243.46 | |
| Mar2022 | ₹12 Cr | 75.92 | |
| Mar2021 | ₹7.04 Cr | - | |
Compare Total Current Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,456.4 Cr | -2.2% | 6.3% | 68.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -2.2% |
6.3% |
68.8% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses